Developer docs
API playgroundTry for free, no card

Search company profiles

Cresco Labs

Full company profile

uuid0002h5d

Namestring
Cresco Labs
Legal namestring
Cresco Labs Inc.
Websiteurl
crescolabs.com
Company typeenum
Public
Founded yearint
2013
Descriptiontext

Cresco Labs Inc. (CRLBF) is a vertically integrated multi-state cannabis operator headquartered in Chicago, Illinois, founded in 2013 and publicly listed on the Canadian Securities Exchange. The company controls the production chain from genetic selection through retail point-of-sale, operating 13 production facilities across 8 states and 74 Sunnyside retail dispensaries across 6 states (Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania). It sells a House of Brands portfolio of cannabis products covering flower, vapes, concentrates, edibles, tinctures, capsules, and topicals under eight consumer brands (Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, Remedi, Sunnyside), supported by patented processing techniques, PhD-led cultivation teams, and standardized operating procedures designed to ensure consistent product quality at scale.

The company generates revenue through two channels: wholesale distribution of branded cannabis products to thousands of third-party dispensaries nationwide, and direct-to-consumer retail through owned Sunnyside dispensaries. Customer segments span medical cannabis patients seeking treatment for conditions such as pain, anxiety, and insomnia, and adult-use recreational consumers in legal states. Cresco Labs expanded internationally in November 2025 with branded flower launches in Germany via partnership with Blossom, and registered U.S. medical cannabis facilities with the DEA following federal rescheduling to Schedule III in May 2026. FY2025 revenue was $656 million against a $140 million net loss, with Q4 2025 generating $162 million in revenue and a 25.0% Adjusted EBITDA margin.

Go-to-market combines direct-to-consumer retail with enterprise field sales targeting new state market entry, complemented by content marketing, in-store wellness advisors, and the SEED social equity initiative. Capital structure includes a $325 million senior secured credit facility maturing 2030, a $50 million Needham Bank revolving facility, and an undrawn $100 million at-the-market equity program with Haywood Securities.

Short descriptiontext

Cresco Labs is a vertically integrated multi-state cannabis operator producing a portfolio of branded cannabis products (Cresco, High Supply, FloraCal, Good News, Wonder, Mindy's, Remedi) sold wholesale and through 74 Sunnyside retail dispensaries across 6 U.S. states, plus recent entry into Germany.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices14 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis cultivation, wholesale cannabis distribution, retail dispensary operations, cannabis brand portfolio, medical cannabis products
Product category
Multi-State Cannabis Operator
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Wholesale Cannabis Product Sales
TypeTransaction Fee
Description

Cresco Labs produces and sells branded cannabis products including flower, vapes, concentrates, edibles, and pre-rolls through wholesale distribution to thousands of dispensaries across the country. Products are sold under brand portfolio including Cresco, High Supply, FloraCal, Good News, Wonder, Mindy's, and Remedi.

crescolabs.com
2Retail Dispensary Operations
TypeTransaction Fee
Description

The company operates Sunnyside dispensaries nationwide, selling cannabis products directly to consumers. With 74 Sunnyside dispensaries across 6 states, retail operations provide direct customer engagement and consumer insights while capturing full margin on retail sales.

crescolabs.com
3International Product Sales
TypeTransaction Fee
Description

Cresco Labs generates revenue through international expansion, including branded flower sales in Germany via partnership with Blossom, representing first entry into the European Union market.

cannabisequipmentnews.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Sunnyside
Description

Retail dispensary brand - judgement-free cannabis shopping experience offering wide array of high quality cannabis products; national retail footprint of 74 dispensaries in 6 states

crescolabs.com
+7 more records
Core offering1 text field

Cresco Labs is a vertically integrated multi-state cannabis operator that cultivates, manufactures, and distributes branded cannabis products (flower, vapes, concentrates, edibles, tinctures, capsules, and pre-rolls) across an eight-brand House of Brands portfolio. The company sells these products both wholesale to thousands of dispensaries nationwide and directly to consumers through 74 owned Sunnyside retail dispensaries across six U.S. states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Q4 2025 revenue of $162 million with 25.0% Adjusted EBITDA margin and $27 million in operating cash flow
+2 more records
Product overview1 text field

Cresco Labs operates a vertically integrated multi-state cannabis company organized around two main pillars: a House of Brands (8 distinct consumer-facing cannabis product brands) and a national retail footprint under the Sunnyside brand. The branded products include Cresco (core flower/concentrates), High Supply (value flower/vapes), FloraCal Farms (premium West Coast small-batch), Good News (social/recreational gummies and vapes), Wonder Wellness Co. (low-dose wellness gummies/mints), Mindys (premium edibles from Chef Mindy Segal), and Remedi (wellness tinctures/capsules/RSO). These brands are sold both wholesale to thousands of dispensaries nationwide and through Cresco Labs' own 74 Sunnyside retail dispensaries across 6 states, supported by 13 production facilities in 8 operational states.

Product and service8 records
1Sunnyside
CategoryRetail Dispensary Brand
Description

Cresco Labs' national retail dispensary brand operating 74 Sunnyside dispensaries across Florida, Illinois, Massachusetts, New York, Ohio, and Pennsylvania. Sunnyside offers a broad assortment of cannabis products curated for different needs, price points, and forms, supported by knowledgeable wellness advisors and an e-commerce platform integrated with the Sunnyside Rewards loyalty program.

2Cresco
CategoryCannabis Brand
Description

Cresco delivers consistent quality, experience, and availability of flower, vapes, concentrates, and pre-rolls, offering reliably excellent cannabis that consumers can depend on finding. The brand is part of the Cresco Labs House of Brands and is distributed both wholesale and through Sunnyside retail dispensaries.

3High Supply
CategoryCannabis Brand
Description

High Supply offers quality cannabis products that are always available, including vape carts, vape pens, flower, popcorn, shake, pre-rolls, and concentrates. Buds are expertly grown and lab-tested.

4FloraCal Farms
CategoryCannabis Brand
Description

Born on the West Coast, FloraCal Farms is committed to rigorous pheno-hunting and small-batch cultivation practices. Flower is always hand-trimmed and expertly cared for, with offerings including flower, vapes, gummies, and pre-rolls.

5Good News
CategoryCannabis Brand
Description

Good News was created for great moments with friends. Each Good News gummy, rechargeable vape pen, and cart is led by the occasion, offering products designed for social experiences.

6Wonder Wellness Co.
CategoryCannabis Brand
Description

Wonder Wellness Co. makes the world of cannabis simple to understand and easy to experience for everyone. The brand's low-dose formulations offered in gummies and mints allow people to control their high for micro-dosing or easing into their cannabis experience.

7Mindy's
CategoryCannabis Brand
Description

James Beard Award-winning Chef Mindy Segal partnered with Cresco Labs to create world-class tasting gummy and chocolate edibles, perfectly dosed for consistent experiences with unbeatable quality.

8Remedi
CategoryCannabis Brand
Description

Remedi offers wellness-minded cannabis delivered in easy forms and precise doses. Available as tinctures, capsules, and RSO (Rick Simpson Oil) in Relief and Rest benefit formulations.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-31
Description

Bloom is expanding its partnership with Cresco Labs to enter Pennsylvania's medical cannabis market with its vape products. This marks Bloom's second market launch with Cresco Labs, aiming to meet the demand for high-performance, consistent medical cannabis vaping devices in Pennsylvania.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-12
Description

Cresco Labs announced the launch of Cresco-branded flower in Germany, its first entry into the EU market, through a partnership with Blossom. The launch aims to establish a foundation for future international expansion and integration into Germany's regulated cannabis market.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Research partnership with Temple University to unlock the potential healing power of cannabis, contributing to scientific advancement and product development.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Vertically-integrated multi-state cannabis operator with cultivation, manufacturing, and retail operations across the Northeast, Midwest, and Florida. Directly comparable vertically integrated model and brand portfolio approach.

TypeDirect peer
Description

Vertically-integrated multi-state cannabis operator with cultivation, manufacturing, and retail dispensaries across medical and adult-use markets. Competes in similar state markets and operates an analogous brand-and-retail dual model.

TypeDirect peer
Description

Vertically-integrated cannabis MSO with a strong Florida retail presence and wholesale brands. Highly comparable operating model and footprint overlap with Cresco, particularly in the Southeast.

TypeDirect peer
Description

Largest US multi-state cannabis operator by retail footprint, with vertically integrated cultivation, processing, and dispensary operations across medical and adult-use markets. Competes head-to-head with Cresco in Florida, Pennsylvania, Massachusetts, and New York.

TypeEmerging player
Description

Multi-state cannabis operator pursuing vertical integration through retail and cultivation acquisitions in Colorado, New Mexico, and Michigan. Smaller scale but follows the same vertically integrated MSO playbook as Cresco.

TypeDirect peer
Description

Vertically-integrated multi-state cannabis operator with a similar brand portfolio, wholesale-to-thousands-of-dispensaries model, and direct retail footprint. Like Cresco, GTI was named in the same federal class-action lawsuit and operates in overlapping states.

TypeEmerging player
Description

Vertically-integrated multi-state cannabis operator with cultivation, processing, and retail operations in Pennsylvania, Virginia, Illinois, Massachusetts, and Nevada. Comparable vertically integrated model at smaller scale.

TypeDirect peer
Description

Multi-state cannabis operator running a House of Brands strategy (MUV, etc.) with retail dispensaries and wholesale distribution. Named alongside Cresco and GTI in the federal class-action lawsuit; comparable business model.

TypeDirect peer
Description

Multi-state cannabis operator with cultivation, processing, and retail dispensaries focused on limited-license states. Comparable vertically integrated model with smaller scale.

TypeEmerging player
Description

Multi-state cannabis operator with superstore retail locations and cultivation/processing capabilities, primarily in Nevada, Florida, and Illinois. Smaller scale but directly comparable business model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses6 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries13 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cresco Labs

Multi-State Cannabis Operatorcrescolabs.com

Cresco Labs is a vertically integrated multi-state cannabis operator producing a portfolio of branded cannabis products (Cresco, High Supply, FloraCal, Good News, Wonder, Mindy's, Remedi) sold wholesale and through 74 Sunnyside retail dispensaries across 6 U.S. states, plus recent entry into Germany.

What Cresco Labs does

Cresco Labs Inc. (CRLBF) is a vertically integrated multi-state cannabis operator headquartered in Chicago, Illinois, founded in 2013 and publicly listed on the Canadian Securities Exchange. The company controls the production chain from genetic selection through retail point-of-sale, operating 13 production facilities across 8 states and 74 Sunnyside retail dispensaries across 6 states (Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania). It sells a House of Brands portfolio of cannabis products covering flower, vapes, concentrates, edibles, tinctures, capsules, and topicals under eight consumer brands (Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, Remedi, Sunnyside), supported by patented processing techniques, PhD-led cultivation teams, and standardized operating procedures designed to ensure consistent product quality at scale.

The company generates revenue through two channels: wholesale distribution of branded cannabis products to thousands of third-party dispensaries nationwide, and direct-to-consumer retail through owned Sunnyside dispensaries. Customer segments span medical cannabis patients seeking treatment for conditions such as pain, anxiety, and insomnia, and adult-use recreational consumers in legal states. Cresco Labs expanded internationally in November 2025 with branded flower launches in Germany via partnership with Blossom, and registered U.S. medical cannabis facilities with the DEA following federal rescheduling to Schedule III in May 2026. FY2025 revenue was $656 million against a $140 million net loss, with Q4 2025 generating $162 million in revenue and a 25.0% Adjusted EBITDA margin.

Go-to-market combines direct-to-consumer retail with enterprise field sales targeting new state market entry, complemented by content marketing, in-store wellness advisors, and the SEED social equity initiative. Capital structure includes a $325 million senior secured credit facility maturing 2030, a $50 million Needham Bank revolving facility, and an undrawn $100 million at-the-market equity program with Haywood Securities.

Cresco Labs firmographics

Firmographics
Name
Cresco Labs
Legal name
Cresco Labs Inc.
Website
https://crescolabs.com
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Cresco Labs is a vertically integrated multi-state cannabis operator producing a portfolio of branded cannabis products (Cresco, High Supply, FloraCal, Good News, Wonder, Mindy's, Remedi) sold wholesale and through 74 Sunnyside retail dispensaries across 6 U.S. states, plus recent entry into Germany.
Ownership category
akta.pro rank

Where Cresco Labs is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices14 records

Markets served

Cresco Labs business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Wholesale Cannabis Product Sales: Cresco Labs produces and sells branded cannabis products including flower, vapes, concentrates, edibles, and pre-rolls through wholesale distribution to thousands of dispensaries across the country. Products are sold under brand portfolio including Cresco, High Supply, FloraCal, Good News, Wonder, Mindy's, and Remedi.
  2. Retail Dispensary Operations: The company operates Sunnyside dispensaries nationwide, selling cannabis products directly to consumers. With 74 Sunnyside dispensaries across 6 states, retail operations provide direct customer engagement and consumer insights while capturing full margin on retail sales.
  3. International Product Sales: Cresco Labs generates revenue through international expansion, including branded flower sales in Germany via partnership with Blossom, representing first entry into the European Union market.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Cresco Labs product offering

Product offering

Core offering

Cresco Labs is a vertically integrated multi-state cannabis operator that cultivates, manufactures, and distributes branded cannabis products (flower, vapes, concentrates, edibles, tinctures, capsules, and pre-rolls) across an eight-brand House of Brands portfolio. The company sells these products both wholesale to thousands of dispensaries nationwide and directly to consumers through 74 owned Sunnyside retail dispensaries across six U.S. states.

Product overview

Cresco Labs operates a vertically integrated multi-state cannabis company organized around two main pillars: a House of Brands (8 distinct consumer-facing cannabis product brands) and a national retail footprint under the Sunnyside brand. The branded products include Cresco (core flower/concentrates), High Supply (value flower/vapes), FloraCal Farms (premium West Coast small-batch), Good News (social/recreational gummies and vapes), Wonder Wellness Co. (low-dose wellness gummies/mints), Mindys (premium edibles from Chef Mindy Segal), and Remedi (wellness tinctures/capsules/RSO). These brands are sold both wholesale to thousands of dispensaries nationwide and through Cresco Labs' own 74 Sunnyside retail dispensaries across 6 states, supported by 13 production facilities in 8 operational states.

Differentiator

Problem solved

Functional benefit

Brands

  • Sunnyside: Retail dispensary brand - judgement-free cannabis shopping experience offering wide array of high quality cannabis products; national retail footprint of 74 dispensaries in 6 states
  • Cresco
  • High Supply
  • FloraCal Farms
  • Good News
  • Wonder Wellness Co.
  • Mindy's
  • Remedi

Products and services

  • Sunnyside Cresco Labs' national retail dispensary brand operating 74 Sunnyside dispensaries across Florida, Illinois, Massachusetts, New York, Ohio, and Pennsylvania. Sunnyside offers a broad assortment of cannabis products curated for different needs, price points, and forms, supported by knowledgeable wellness advisors and an e-commerce platform integrated with the Sunnyside Rewards loyalty program.
  • Cresco Cresco delivers consistent quality, experience, and availability of flower, vapes, concentrates, and pre-rolls, offering reliably excellent cannabis that consumers can depend on finding. The brand is part of the Cresco Labs House of Brands and is distributed both wholesale and through Sunnyside retail dispensaries.
  • High Supply High Supply offers quality cannabis products that are always available, including vape carts, vape pens, flower, popcorn, shake, pre-rolls, and concentrates. Buds are expertly grown and lab-tested.
  • FloraCal Farms Born on the West Coast, FloraCal Farms is committed to rigorous pheno-hunting and small-batch cultivation practices. Flower is always hand-trimmed and expertly cared for, with offerings including flower, vapes, gummies, and pre-rolls.
  • Good News Good News was created for great moments with friends. Each Good News gummy, rechargeable vape pen, and cart is led by the occasion, offering products designed for social experiences.
  • Wonder Wellness Co. Wonder Wellness Co. makes the world of cannabis simple to understand and easy to experience for everyone. The brand's low-dose formulations offered in gummies and mints allow people to control their high for micro-dosing or easing into their cannabis experience.
  • Mindy's James Beard Award-winning Chef Mindy Segal partnered with Cresco Labs to create world-class tasting gummy and chocolate edibles, perfectly dosed for consistent experiences with unbeatable quality.
  • Remedi Remedi offers wellness-minded cannabis delivered in easy forms and precise doses. Available as tinctures, capsules, and RSO (Rick Simpson Oil) in Relief and Rest benefit formulations.

Quantifiable outcome

  • Q4 2025 revenue of $162 million with 25.0% Adjusted EBITDA margin and $27 million in operating cash flow
  • +2 more outcomes

Companies that use Cresco Labs

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Cresco Labs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cresco Labs partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • BloomcoreStrategic or Co-development Partner · 31 March 2026Bloom is expanding its partnership with Cresco Labs to enter Pennsylvania's medical cannabis market with its vape products. This marks Bloom's second market launch with Cresco Labs, aiming to meet the demand for high-performance, consistent medical cannabis vaping devices in Pennsylvania.
  • BlossomcoreStrategic or Co-development Partner · 12 November 2025Cresco Labs announced the launch of Cresco-branded flower in Germany, its first entry into the EU market, through a partnership with Blossom. The launch aims to establish a foundation for future international expansion and integration into Germany's regulated cannabis market.
  • Temple UniversityminorStrategic or Co-development PartnerResearch partnership with Temple University to unlock the potential healing power of cannabis, contributing to scientific advancement and product development.

Scale indicators10 records

Recent moves10 records

Expansion highlights7 records

Cresco Labs competitors and assessment

Company assessment

Direct peers

  • Ayr Wellness: Vertically-integrated multi-state cannabis operator with cultivation, manufacturing, and retail operations across the Northeast, Midwest, and Florida. Directly comparable vertically integrated model and brand portfolio approach.
  • The Cannabist Company (formerly Columbia Care): Vertically-integrated multi-state cannabis operator with cultivation, manufacturing, and retail dispensaries across medical and adult-use markets. Competes in similar state markets and operates an analogous brand-and-retail dual model.
  • Trulieve Cannabis: Vertically-integrated cannabis MSO with a strong Florida retail presence and wholesale brands. Highly comparable operating model and footprint overlap with Cresco, particularly in the Southeast.
  • Curaleaf Holdings: Largest US multi-state cannabis operator by retail footprint, with vertically integrated cultivation, processing, and dispensary operations across medical and adult-use markets. Competes head-to-head with Cresco in Florida, Pennsylvania, Massachusetts, and New York.
  • Green Thumb Industries: Vertically-integrated multi-state cannabis operator with a similar brand portfolio, wholesale-to-thousands-of-dispensaries model, and direct retail footprint. Like Cresco, GTI was named in the same federal class-action lawsuit and operates in overlapping states.
  • Verano Holdings: Multi-state cannabis operator running a House of Brands strategy (MUV, etc.) with retail dispensaries and wholesale distribution. Named alongside Cresco and GTI in the federal class-action lawsuit; comparable business model.
  • Ascend Wellness Holdings: Multi-state cannabis operator with cultivation, processing, and retail dispensaries focused on limited-license states. Comparable vertically integrated model with smaller scale.

Emerging players

  • Schwazze: Multi-state cannabis operator pursuing vertical integration through retail and cultivation acquisitions in Colorado, New Mexico, and Michigan. Smaller scale but follows the same vertically integrated MSO playbook as Cresco.
  • Jushi Holdings: Vertically-integrated multi-state cannabis operator with cultivation, processing, and retail operations in Pennsylvania, Virginia, Illinois, Massachusetts, and Nevada. Comparable vertically integrated model at smaller scale.
  • Planet 13 Holdings: Multi-state cannabis operator with superstore retail locations and cultivation/processing capabilities, primarily in Nevada, Florida, and Illinois. Smaller scale but directly comparable business model.

Market position

Strengths5 records

Weaknesses6 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cresco Labs social profiles

Digital presence

Cresco Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cresco Labs leadership team

Management profile

Number of profiles

Profiles8 records

Cresco Labs subsidiaries and ownership

Company hierarchy

Subsidiaries13 records

Cresco Labs funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cresco Labs M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cresco Labs

What does Cresco Labs do?

Cresco Labs is a vertically integrated multi-state cannabis operator that cultivates, manufactures, and distributes branded cannabis products (flower, vapes, concentrates, edibles, tinctures, capsules, and pre-rolls) across an eight-brand House of Brands portfolio. The company sells these products both wholesale to thousands of dispensaries nationwide and directly to consumers through 74 owned Sunnyside retail dispensaries across six U.S. states.

Is Cresco Labs a public or private company?

Cresco Labs is a public company. It is classified as public and is currently operating.

When was Cresco Labs founded?

Cresco Labs was founded in 2013. It employs 1,001 to 5,000 people.

Where is Cresco Labs based?

Cresco Labs is headquartered in Chicago, United States, in the North America region.

How does Cresco Labs make money?

Three revenue lines are on record. Wholesale Cannabis Product Sales are the primary driver. The others are retail Dispensary Operations and international Product Sales.

Who are Cresco Labs's main competitors?

Direct peers on record are Ayr Wellness, The Cannabist Company (formerly Columbia Care), Trulieve Cannabis, Curaleaf Holdings, Green Thumb Industries, Verano Holdings and Ascend Wellness Holdings. Emerging players are Schwazze, Jushi Holdings and Planet 13 Holdings.

Does Cresco Labs have an API?

No public API is recorded for Cresco Labs.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanCresco Labs files supplement on super-voting share amendmentCresco Labs filed a supplement to its management information circular for its annual general and special meeting on October 30, 2026, enhancing disclosure on a proposed amendment to its super-voting shares and related minority approval requirements. The meeting will be held via live audio webcast, with shareholders entitled to vote as of September 15, 2026.AInvestThe Shareholders Cresco Outvotes Decide Whether It Keeps Outvoting ThemCresco Labs shareholders will vote on October 30 to extend the conversion delay of super-voting shares from 1 to 3 years after listing. The super-voting shares, held by CEO Charles Bachtell, control about 74% of voting power, and the extension requires minority shareholder approval. The move aims to preserve insider control amid stalled federal cannabis reform and delayed exchange listing prospects.Markets DailyCresco Labs (OTCMKTS:CRLBF) Upgraded to Strong-Buy at Zacks ResearchZacks Research upgraded Cresco Labs from hold to strong-buy, while Alliance Global Partners reiterated a buy. The company reported Q2 EPS of $0.04, beating the -$0.02 estimate, with revenue of $173.34 million. Shares opened at $0.64, with a 52-week range of $0.59 to $2.30.American Banking and Market NewsCresco Labs (OTCMKTS:CRLBF) Stock Rating Upgraded by Zacks ResearchZacks Research upgraded Cresco Labs from hold to strong-buy, and Alliance Global Partners restated a buy rating. The stock opened at $0.64, and the company reported Q2 EPS of $0.04, beating the -$0.02 consensus estimate. Analysts predict a -0.04 EPS for the current fiscal year.MorningstarCresco Labs Announces Filing of Management Information Circular for Annual General and Special MeetingCresco Labs filed its management information circular for an annual general and special meeting on October 30, 2026, to vote on three resolutions. The proposals include a share exchange to create a new parent company, a redomicile to Delaware, and an extension of the multiple voting share sunset date, all aimed at positioning the company for a U.S. listing.Stock TitanCresco Labs Names Former Cboe CEO to BoardCresco Labs appointed Edward Tilly as an independent director and audit committee member, effective September 18, 2026. Tilly, former CBOE chairman and CEO, brings over 35 years of exchange and capital markets experience. The appointment brings the board to eight directors.AInvestCresco Labs: A Proven, Cheap Pennsylvania Deal Still Awaits a Stalled CatalystCresco Labs acquired nine Pennsylvania dispensaries for about $50 million, making it the state's top medical-marijuana retailer. The deal, paid with cash and a seller note, caused a 4% stock drop as investors focused on cash usage and stalled adult-use legalization. The purchase is a modest bolt-on, with value pending a catalyst from Harrisburg.Pulse 2.0Cresco Labs Acquires Nine Pennsylvania Dispensaries For $50 MillionCresco Labs completed the acquisition of PharmaCann Penn for $50 million, adding nine Pennsylvania medical marijuana dispensaries. The deal makes Cresco the state's top retailer and wholesaler, with the purchase funded by cash and a seller note. Cresco expects the acquisition to be immediately accretive to revenue, margins, and cash flow.citybizCresco Labs Acquires Nine Pennsylvania Dispensaries for $50MCresco Labs completed a $50 million acquisition of nine operating medical marijuana dispensaries in Pennsylvania from PharmaCann Penn. The deal makes Cresco Pennsylvania's largest medical marijuana retailer and complements its wholesale leadership. The company expects the acquisition to be immediately accretive to revenue, margins, and cash flow.Investing.comCresco Labs acquires PharmaCann for $50 million in Pennsylvania By Investing.comCresco Labs completed its acquisition of PharmaCann Penn, LLC for $50 million, including nine operational retail medical marijuana dispensaries in Pennsylvania. The deal was paid in cash and a seller note on a cash-free, debt-free basis. Pennsylvania's medical marijuana market generated over $1.1 billion in annual sales last year.